Harvard Pulmonary and Critical Care Medicine 2023

Harvard Pulmonary and Critical Care Medicine 2023

OVERVIEW

• Post-acute sequelae of COVID-19
• Chronic cough
• COPD
• Asthma
• Lung nodules
• Lung cancer
• Sleep-disordered breathing
• GERD
• Sepsis
• ARDS
• Sarcoidosis
• IPF
• Pleural disease
• Pneumonia
• Tuberculosis
• Surgical emergencies
• Thromboembolism
• Lung transplantation
• Neurologic issues in the ICU
• Septic shock
• Interstitial lung disease
• Bronchiectasis
• Cystic fibrosis
• Atypical mycobacterial disease
• Pulmonary hypertension
• Cardiopulmonary disorders
• Complications from cardiac arrest
• Hypersensitivity pneumonitis
• Occupational and environmental lung disease
• Acute respiratory failure
• Vaping-related lung disease
• Hemorrhage and ANCA-associated disease

REASONS TO ATTEND IN 2023

• COVID-19, PASC, and emerging diseases
• Advanced techniques in interventional pulmonology
• High-flow oxygen therapy for respiratory failure
• New biologics for asthma
• Lung microbiome: emerging implications for lung health
• Emerging evidence for targeted temperature management
• Evaluating occupational and environmental lung disease
• Prescribing medications for interstitial lung disease
• Pulmonary embolus: the latest treatment strategies
• State-of-the-art management of the critically ill patient
• Guidance to conduct end-of-life discussions
• Updates in pulmonary pathology
• New treatment options in cystic fibrosis
• Handling neurologic and surgical emergencies in the medical ICU
• The state of the art in interventional bronchoscopy
• The most current guidelines for treating sepsis
• Evidence-based treatment of ARDS
• Updates on vaping-related lung disease
• New therapeutics in the age of immunology
• Guidance to navigate controversies surrounding therapeutic hypothermia and post-cardiac arrest prognosis
• New approaches that improve outcomes for patients with unexplained chronic cough
• Current guidelines for management of pulmonary nodules
• Targeted therapies and immunotherapies for lung cancer
• When to consider lung transplantation and eligibility
• When and how to use the newest drugs in IPF
• Expert advice on atypical mycobacterial diagnostics and therapy
• New concepts in the use of vasopressors in septic shock
• New drugs and combinations in pulmonary hypertension
• New evidence on sedation, analgesia, and early mobility
• Point-of-care pulmonary ultrasound in the intensive care unit